Inhibition of luciferase expression by synthetic hammerhead ribozymes and their cellular uptake

被引:23
作者
Bramlage, B [1 ]
Alefelder, S [1 ]
Marschall, P [1 ]
Eckstein, F [1 ]
机构
[1] Max Planck Inst Expt Med, D-37075 Gottingen, Germany
关键词
D O I
10.1093/nar/27.15.3159
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two synthetic hammerhead ribozymes, one unmodified and the other with 2'-modifications and four phosphorothioate groups, targeting a single GUA site in the luciferase mRNA, were compared for their inhibition of gene expression in cell culture and their cellular uptake was also analysed. A HeLa X1/5 cell line stably expressing luciferase, under an inducible promoter, was treated with these ribozymes by liposome-mediated transfection to determine their activity. Luciferase expression in cells was inhibited to similar to 50% with little difference between the unmodified and the 2'-modified ribozyme, A similar degree of inhibition was observed with two catalytically inactive ribozymes, indicating that inhibition was mainly due to an anti-sense effect, A ribozyme carrying a cholesterol moiety, applied to the cells without carrier, showed no inhibition, Northern blotting indicated a similar amount of cellular uptake of all ribozymes, The unmodified ribozyme was essentially evenly distributed between cytoplasm and nucleus, whereas a higher proportion of the phosphorothioate-containing ribozyme was observed in the nucleus. Fluorescence microscopy, including confocal microscopy using 5'-fluorescein-labelled ribozymes, showed that the unmodified and 2'-modified ribozymes were present in the cytoplasm and in the nucleus to a similar extent, whereas the fluorescence of the phosphorothioate-containing ribozyme was much stronger in the nucleus. Both ribozymes inhibited luciferase expression to a comparable degree, suggesting that the ribozyme in the nucleus did not contribute significantly to the inhibition. Ribozymes with a cholesterol moiety were predominantly trapped in the cell membrane, explaining their inability to interfere with gene expression.
引用
收藏
页码:3159 / 3167
页数:9
相关论文
共 48 条
[1]  
Alahari SK, 1996, MOL PHARMACOL, V50, P808
[2]   TRANSLATION OF 2'-MODIFIED MESSENGER-RNA IN-VITRO AND IN-VIVO [J].
AURUP, H ;
SIEBERT, A ;
BENSELER, F ;
WILLIAMS, D ;
ECKSTEIN, F .
NUCLEIC ACIDS RESEARCH, 1994, 22 (23) :4963-4968
[3]  
Bennett CF, 1998, APPLIED ANTISENSE OLIGONUCLEOTIDE TECHNOLOGY, P129
[4]  
Bertrand E, 1997, RNA, V3, P75
[5]   The structure, function and application of the hammerhead ribozyme [J].
Birikh, KR ;
Heaton, PA ;
Eckstein, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 245 (01) :1-16
[6]   Designing ribozymes for the inhibition of gene expression [J].
Bramlage, B ;
Luzi, E ;
Eckstein, F .
TRENDS IN BIOTECHNOLOGY, 1998, 16 (10) :434-438
[7]   Transient transfection of a synthetic hammerhead ribozyme targeted against human MGMT gene to cells in culture potentiates the genotoxicity of the alkylation damage induced by mitozolomide [J].
Citti, L ;
Eckstein, F ;
Capecchi, B ;
Mariani, L ;
Nevischi, S ;
Poggi, A ;
Rainaldi, G .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1999, 9 (02) :125-133
[8]  
CLARENC JP, 1993, ANTI-CANCER DRUG DES, V8, P81
[9]  
Dorai T, 1997, ANTICANCER RES, V17, P3307
[10]   Enhanced downregulation of the p75 nerve growth factor receptor by cholesteryl and bis-cholesteryl antisense oligonucleotides [J].
Epa, WR ;
Rong, P ;
Bartlett, PF ;
Coulson, EJ ;
Barrett, GL .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (06) :489-498